How much time elapses between a blow to the head and the start of damage associated with Alzheimer's disease?
A device that makes it possible to track the effects of concussive force on a functioning cluster of brain cells suggests the answer is in hours. The" on a chip" being developed at Purdue University opens a window into a cause and effect that announces itself with the passage of decades but is exceedingly difficult to trace back to its origins.
The device can also be used to test possible therapeutics, including drugs known to reduce acrolein levels. In the current study, Shi's team used the device to show that the drug hydralazine, a known acrolein scavenger that is approved by the U.S. Food and Drug Administration for lowering blood pressure, reduces the amount of acrolein and levels of misfolded AB42 produced in the cluster of neurons after a hit.
Danmark Seneste Nyt, Danmark Overskrifter
Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.
Scientists create 'hat' that detects Alzheimer's years before first symptomsIt has been hailed a 'fitness tracker for the brain'.
Læs mere »
Time-restricted feeding reverses Alzheimer's symptoms in mice, offers new hope for accessible treatmentResearchers explore the therapeutic potential of circadian-modulating interventions to treat Alzheimer’s disease.
Læs mere »
Revolutionary new bedtime accessory detects Alzheimer's disease while you sleepIt has been hailed a 'fitness tracker for the brain'.
Læs mere »
Influenza and pneumonia vaccinations associated with reduced risk of Alzheimer’s diseaseFlu (influenza) and pneumonia vaccinations are associated with reduced risk of Alzheimer’s disease, according to new research reported at the Alzheimer’s Association International Conference (AAIC) 2020.
Læs mere »
How diet and exercise may rewrite the Alzheimer's script at a molecular levelResearchers explore how lifestyle changes like diet and physical activity can influence microRNA expression in Alzheimer's patients, potentially offering new therapeutic avenues. The study fills a research gap in understanding how such lifestyle modifications could affect molecular mechanisms implicated in Alzheimer’s disease.
Læs mere »
Online test nails early Alzheimer's diagnosis with biomarker precisionResearchers have developed a novel digital cognitive testing platform, using the Oxford Cognitive Testing Portal, that correlates with serological biomarkers to accurately measure cognitive impairment in Alzheimer's patients. The study highlights the platform's effectiveness in capturing subtle signs of impairment, potentially revolutionizing early diagnosis and tracking of Alzheimer's disease.
Læs mere »